Showing results (561-570 of 5,696) with videos related to

Sort By:
Pageof 570
Medical Oncology (Northwood, London, England)|February 11, 2010
Prognostic significance of telomerase activity and some tumor markers in non-small cell lung cancerMaha Hashim, Magda Sayed, Nervana Samy, et al.
Medical Oncology (Northwood, London, England)|May 6, 2018
Reclassification of risk in an emergency referral center: the need for a specific tool for the classification of onco-hematological patients. A cross-sectional studyLuciana Lopes Manfredini, Gislene Padilha Dos Santos, Ana Fernanda Yamazaki Centrone, et al.
Medical Oncology (Northwood, London, England)|May 31, 2017
Paradigm shift of therapeutic management of brain metastases in EGFR-mutant non-small cell lung cancer in the era of targeted therapyAkimasa Sekine, Hiroaki Satoh
Medical Oncology (Northwood, London, England)|June 3, 2017
Clinical significance of androgen secretion disorders in men with a malignancyPawel J Wiechno, Grazyna M Poniatowska, Wojciech Michalski, et al.
Medical Oncology (Northwood, London, England)|June 3, 2017
Peribiliary liver metastases MR findingsVincenza Granata, Roberta Fusco, Orlando Catalano, et al.
Medical Oncology (Northwood, London, England)|June 3, 2017
Downregulation of TRPM7 suppressed migration and invasion by regulating epithelial-mesenchymal transition in prostate cancer cellsLiang Chen, Rui Cao, Gang Wang, et al.
Medical Oncology (Northwood, London, England)|April 29, 2017
Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpressionDaniela Alterio, Giulia Marvaso, Fausto Maffini, et al.
Medical Oncology (Northwood, London, England)|March 6, 2010
Validation of a clinical prognostic model in Chinese patients with metastatic and advanced pretreated non-small cell lung cancer treated with gefitinibFenghua Wang, Yang Zhang, Hongyun Zhao, et al.
Medical Oncology (Northwood, London, England)|April 28, 2018
Frequency of pathogenic germline mutations in cancer susceptibility genes in breast cancer patientsRaman Preet Kaur, Gowhar Shafi, Raja Paramjeet Singh Benipal, et al.
Medical Oncology (Northwood, London, England)|May 9, 2018
Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinomaPawel Chrom, Maciej Kawecki, Rafal Stec, et al.
Pageof 570